(Q34522251)

2 August 2017

Alpha-1-antitrypsin-Pittsburgh. A potent inhibitor of human plasma factor XIa, kallikrein, and factor XIIf (English)

1 reference

2 August 2017

C F Scott

1

1 reference

2 August 2017

R W Carrell

2

1 reference

2 August 2017

C B Glaser

3

1 reference

2 August 2017

F Kueppers

4

1 reference

2 August 2017

J H Lewis

5

1 reference

2 August 2017

R W Colman

6

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 1986

1 reference

Journal of Clinical Investigation

2 August 2017

1 reference

2 August 2017

77

1 reference

2 August 2017

631-634

1 reference

2 August 2017

2

1 reference

Inactivation of factor XIa by plasma protease inhibitors: predominant role of alpha 1-protease inhibitor and protective effect of high molecular weight kininogen

2 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Structure and variation of human alpha 1-antitrypsin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Acquired antibody to factor XI in a patient with congenital factor XI deficiency

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Protection of human plasma kallikrein from inactivation by C1 inhibitor and other protease inhibitors. The role of high molecular weight kininogen.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg), a fatal bleeding disorder

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Synthesis in yeast of a functional oxidation-resistant mutant of human alpha-antitrypsin.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Detection of a new heparin-dependent inhibitor of thrombin in human plasma

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Immunochemical quantitation of antigens by single radial immunodiffusion

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

The Purification and Mechanism of Action of Human Antithrombin-Heparin Cofactor

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Substrates of Hageman factor. I. Isolation and characterization of human factor XI (PTA) and inhibition of the activated enzyme by alpha 1-antitrypsin

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Synthesis in E. coli of alpha 1-antitrypsin variants of therapeutic potential for emphysema and thrombosis.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Recombinant alpha 1-antitrypsin Pittsburgh (Met 358----Arg) is a potent inhibitor of plasma kallikrein and activated factor XII fragment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

The regulation of human factor XIIa by plasma proteinase inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Activation of human factor IX (Christmas factor)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Activation of human factor XI (plasma thromboplastin antecedent) by factor XIIa (activated Hageman factor)

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Antithrombin Pittsburgh: an alpha1-antitrypsin variant causing hemorrhagic disease

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Alpha1-antitrypsin: further genetic heterogeneity revealed by isoelectric focusing

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Human Plasma Prekallikrein: a Rapid High-Yield Method for Purification

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Comparison of the inhibition of thrombin by three plasma protease inhibitors

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

The heparin-enhanced antithrombin III/thrombin reaction is saturable with respect to both thrombin and antithrombin III.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=423401

Genetically determined differences in the response of alpha1-antitrypsin levels in human serum to typhoid vaccine

27 October 2018

1 reference

12 December 2020

Binding of thrombin to antithrombin III

1 reference

12 December 2020

Plasma Kallikrein and Hageman Factor in Gram-Negative Bacteremia

1 reference

12 December 2020

Determination of prekallikrein in human plasma: optimal conditions for activating prekallikrein

1 reference

12 December 2020

Activation of bovine factor XII (Hageman factor) by plasma kallikrein

1 reference

12 December 2020

Some properties of antithrombin-III and its concentration in human plasma

1 reference

12 December 2020

Thrombin generation and formation of thrombin-antithrombin III complexes in congenital antithrombin III deficiency

1 reference

12 December 2020

The isolation of alpha-1-protease inhibitor by a unique procedure designed fo industrial application

1 reference

12 December 2020

Studies on the mechanism of thrombin-catalyzed hemostatic reactions in blood platelets

1 reference

12 December 2020

Amidolytic assay of human factor XI in plasma: comparison with a coagulant assay and a new rapid radioimmunoassay

1 reference

12 December 2020

A genetically engineered mutant of alpha 1-antitrypsin protects connective tissue from neutrophil damage and may be useful in lung disease

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI112346

1 reference

2 August 2017

1 reference

2 August 2017

1 reference